Dr. Shahriari’s visit of Sputnik V vaccine production lines
According to the public relations of the Actover group, Dr. Shahriari, the head of the health commission of the Parliament of Iran, together with some members of the parliament and the accompanying delegation, visited the production lines of the Russian Sputnik vaccine at the Actoverco’s factory.
We must use the capacity of the private sector to provide the COVID-19 vaccine
Commander of Corona Countermeasures Headquarters in the Tehran metropolis, noting that today the country’s pharmaceutical industry has reached a very high level.
Production of more the 600 thousands of Remdesivir vials
“Currently, about 6 million people in the country are constantly taking various drugs of Actoverco” said the director of the Actoverco’s factory.
Inauguration of Actotech pharmaceutical and food accelerator with the presence of Dr. Sattari, Vice President for Science and Technology
According to the public relations of the Actover Group, Dr. Ali Naraghi at the opening of the pharmaceutical and food accelerator said: “This Corporation is the result of thinking about creation of a link between industry and the university.
Interview with the CEO of Actoverco
According to the public relations of Actover Group, Nahaleh Naraghi is the CEO of Actoverco. Actoverco is a leading company in the field of producing high quality drugs in accordance with the latest international standards.
Four great achievements
efforts of the children of Iran in the Actover Pharmaceutical Group, four great achievements in the current situation are presented as a drop from the boundless sea of service to the noble people of our country.
Unveiling of 3 new drugs of Actoverco Company among the neurology group
On December 26, 2019, during a glorious ceremony attended by more than 180 psychiatrists and neurologists, three new drugs of Actoverco Company were officially unveiled.
Explanation of the manufacturer of the news-making drug “Losartan”
Following the Food and Drug Administration’s order to collect Losartan drug with Indian active ingredient from the supply level, the Iranian company “Actoverco” announced in a statement that it has issued an immediate stop order to sell Losartan drug to distribution companies and the drug collection process from the pharmacies has started.
Actoverco company announcement
Signing agreement of cooperation and establishment of a new innovation center in the Actoverco company
Signing agreement of cooperation for the establishment of the “Actotech Innovation Center” and the beginning of the official knowledge-based activities in the Actoverco company was held in the presence of the Vice President for Science and Technology.
Another big step of Iran in the production of anti-cancer drugs
The largest factory for the production of anti-cancer drugs in the Middle East, as well as the biotechnology department of the pharmaceutical group, was put into operation in Alborz with the presence of the Minister of Health.
Actoverco received 90.8 million Euros of governmental currency in the first half of this year
The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”